Zobrazeno 1 - 8
of 8
pro vyhledávání: '"H. A. Jaaskela-Saari"'
Autor:
Reidar Grénman, Jussi Tarkkanen, H. A. Jaaskela-Saari, Hans Ramsay, Timo Paavonen, Kalevi Kairemo
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 20:426-435
Labeling of bleomycin with Auger-emitter Indium-111 increases cytotoxicity in squamous cell cancer (SCC) cell lines, as we have reported earlier. In this study, we investigated whether (111)In- BLMC is toxic and effective in vivo among SCC-xenografte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d280661b497683406726cc0676b4e38e
https://doi.org/10.1089/cbr.2005.20.426
https://doi.org/10.1089/cbr.2005.20.426
Autor:
Hans Ramsay, Timo Paavonen, Sven-Erik Strand, Antti Jekunen, Kaj Ljunggren, H. A. Jaaskela-Saari, K. Liewendahl, Kalevi Kairemo, Magnus Tagesson, Sauli Savolainen
Publikováno v:
European Journal of Nuclear Medicine. 23:631-638
Bleomycin (BLM) is used for the treatment of head and neck cancer. In order to improve the effectiveness of this chemotherapeutic drug, BLM was combined with indium-111. A complex of these agents (111In-BLMC), formed at low pH, was injected intraveno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d57cf3e04f7eae44cf40dceee4cf0f4
https://doi.org/10.1007/bf00834524
https://doi.org/10.1007/bf00834524
Autor:
Petri Salven, Tuija Ikonen, Heikki Joensuu, Severi Mattila, Jonas Bondestam, H. A. Jaaskela-Saari, Mauri Lepäntalo
Publikováno v:
The American Journal of Surgery. 179:57-59
Background: Vascular endothelial growth factor (VEGF) is a hypoxia-induced endothelial cellspecific mitogen, which is angiogenic in vivo and up-regulated in several malignancies. VEGF can be used as a prognostic marker, but the effect of surgical tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a07df397e08fb392230236a8470199e3
https://doi.org/10.1016/s0002-9610(99)00253-6
https://doi.org/10.1016/s0002-9610(99)00253-6
Publikováno v:
International journal of radiation biology. 73(5)
Purpose: To investigate the cytotoxicity of bleomycin (BLM), two Auger-emitting bleomycin complexes (indium-111 ( 111 In)-BLMC) and 111 InCl 3 in three squamous cell cancer (SCC) cell lines. Material and methods: Three recently established SCC cell l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf3c0c68439d006737a79c69229ccfb
https://pubmed.ncbi.nlm.nih.gov/9652815
https://pubmed.ncbi.nlm.nih.gov/9652815
Publikováno v:
Acta oto-laryngologica. Supplementum. 529
Bleomycin (BLM) is a natural antibiotic, toxic to dividing cells (G2/M-phase), also proven effective in squamous cell carcinomas (SCC). We have clinically shown that a short-range beta-emitting radionuclide combined to bleomycin (In-111-BLMC) is a tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7617e901ce87c9ef0a20414cdefdc0e1
https://pubmed.ncbi.nlm.nih.gov/9288321
https://pubmed.ncbi.nlm.nih.gov/9288321
Autor:
Jalilian, A. R.1 ajalilian@nrcam.org, Rowshanfarzad, P.1, Sabet, M.2, Novinrooz, A.3, Raisali, G.1
Publikováno v:
Journal of Radioanalytical & Nuclear Chemistry. Jun2005, Vol. 264 Issue 3, p617-621. 5p.
Autor:
Srinivas, Ramishetti, Satterlee, Andrew, Wang, Yuhua, Zhang, Yuan, Wang, Yongjun, Huang, Leaf
Publikováno v:
Nanoscale; 11/28/2015, Vol. 7 Issue 44, p18542-18551, 10p
Publikováno v:
Acta Oto-Laryngologica; 1997, Vol. 117 Issue S529, p241-244, 4p